Selected research
Industry Research
Home Pet Deworming Medicine Industry Research Report 2026
Market perspective
The global Home Pet Deworming Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Home Pet Deworming Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Home Pet Deworming Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Home Pet Deworming Medicine include Zoetis, Merck & Co, Inc., Sava Healthcare Limited, Boehringer Ingelheim International GmbH, Ceva, Elanco, Virbac, PetIQ, LLC and Liquid Fence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Home Pet Deworming Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Home Pet Deworming Medicine Market by Company
Zoetis
Merck & Co, Inc.
Sava Healthcare Limited
Boehringer Ingelheim International GmbH
Ceva
Elanco
Virbac
PetIQ, LLC
Liquid Fence
Bird-X
HortiCentre
Green Gardener
The Big Cheese
Yorkshire Trading Company
Ramical
Beaphar
Agland
Home Pet Deworming Medicine Segment by Type
Internal Deworming
External Deworming
Home Pet Deworming Medicine Segment by Application
Cats
Dogs
Others
Home Pet Deworming Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Pet Deworming Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Pet Deworming Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Pet Deworming Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Home Pet Deworming Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Home Pet Deworming Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Home Pet Deworming Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Internal Deworming
- External Deworming
Applications
- Cats
- Dogs
- Others
Companies covered
- Zoetis
- Merck & Co, Inc.
- Sava Healthcare Limited
- Boehringer Ingelheim International GmbH
- Ceva
- Elanco
- Virbac
- PetIQ, LLC
- Liquid Fence
- Bird-X
- HortiCentre
- Green Gardener
- The Big Cheese
- Yorkshire Trading Company
- Ramical
- Beaphar
- Agland
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Home Pet Deworming Medicine Market Size (2021-2032)
- 2.2.2 Global Home Pet Deworming Medicine Sales (2021-2032)
- 2.2.3 Global Home Pet Deworming Medicine Market Average Price (2021-2032)
- 2.3 Home Pet Deworming Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Internal Deworming
- 2.3.3 External Deworming
- 2.4 Home Pet Deworming Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cats
- 2.4.3 Dogs
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Home Pet Deworming Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Home Pet Deworming Medicine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Home Pet Deworming Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Home Pet Deworming Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Home Pet Deworming Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Home Pet Deworming Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Home Pet Deworming Medicine, Product Type & Application
- 3.8 Global Manufacturers of Home Pet Deworming Medicine, Established Date
- 3.9 Global Home Pet Deworming Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Home Pet Deworming Medicine Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Merck & Co, Inc.
- 4.2.1 Merck & Co, Inc. Company Information
- 4.2.2 Merck & Co, Inc. Business Overview
- 4.2.3 Merck & Co, Inc. Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co, Inc. Home Pet Deworming Medicine Product Portfolio
- 4.2.5 Merck & Co, Inc. Recent Developments
- 4.3 Sava Healthcare Limited
- 4.3.1 Sava Healthcare Limited Company Information
- 4.3.2 Sava Healthcare Limited Business Overview
- 4.3.3 Sava Healthcare Limited Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sava Healthcare Limited Home Pet Deworming Medicine Product Portfolio
- 4.3.5 Sava Healthcare Limited Recent Developments
- 4.4 Boehringer Ingelheim International GmbH
- 4.4.1 Boehringer Ingelheim International GmbH Company Information
- 4.4.2 Boehringer Ingelheim International GmbH Business Overview
- 4.4.3 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Product Portfolio
- 4.4.5 Boehringer Ingelheim International GmbH Recent Developments
- 4.5 Ceva
- 4.5.1 Ceva Company Information
- 4.5.2 Ceva Business Overview
- 4.5.3 Ceva Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ceva Home Pet Deworming Medicine Product Portfolio
- 4.5.5 Ceva Recent Developments
- 4.6 Elanco
- 4.6.1 Elanco Company Information
- 4.6.2 Elanco Business Overview
- 4.6.3 Elanco Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Elanco Home Pet Deworming Medicine Product Portfolio
- 4.6.5 Elanco Recent Developments
- 4.7 Virbac
- 4.7.1 Virbac Company Information
- 4.7.2 Virbac Business Overview
- 4.7.3 Virbac Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Virbac Home Pet Deworming Medicine Product Portfolio
- 4.7.5 Virbac Recent Developments
- 4.8 PetIQ, LLC
- 4.8.1 PetIQ, LLC Company Information
- 4.8.2 PetIQ, LLC Business Overview
- 4.8.3 PetIQ, LLC Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 PetIQ, LLC Home Pet Deworming Medicine Product Portfolio
- 4.8.5 PetIQ, LLC Recent Developments
- 4.9 Liquid Fence
- 4.9.1 Liquid Fence Company Information
- 4.9.2 Liquid Fence Business Overview
- 4.9.3 Liquid Fence Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Liquid Fence Home Pet Deworming Medicine Product Portfolio
- 4.9.5 Liquid Fence Recent Developments
- 4.10 Bird-X
- 4.10.1 Bird-X Company Information
- 4.10.2 Bird-X Business Overview
- 4.10.3 Bird-X Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bird-X Home Pet Deworming Medicine Product Portfolio
- 4.10.5 Bird-X Recent Developments
- 4.11 HortiCentre
- 4.11.1 HortiCentre Company Information
- 4.11.2 HortiCentre Business Overview
- 4.11.3 HortiCentre Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HortiCentre Home Pet Deworming Medicine Product Portfolio
- 4.11.5 HortiCentre Recent Developments
- 4.12 Green Gardener
- 4.12.1 Green Gardener Company Information
- 4.12.2 Green Gardener Business Overview
- 4.12.3 Green Gardener Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Green Gardener Home Pet Deworming Medicine Product Portfolio
- 4.12.5 Green Gardener Recent Developments
- 4.13 The Big Cheese
- 4.13.1 The Big Cheese Company Information
- 4.13.2 The Big Cheese Business Overview
- 4.13.3 The Big Cheese Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 The Big Cheese Home Pet Deworming Medicine Product Portfolio
- 4.13.5 The Big Cheese Recent Developments
- 4.14 Yorkshire Trading Company
- 4.14.1 Yorkshire Trading Company Company Information
- 4.14.2 Yorkshire Trading Company Business Overview
- 4.14.3 Yorkshire Trading Company Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Yorkshire Trading Company Home Pet Deworming Medicine Product Portfolio
- 4.14.5 Yorkshire Trading Company Recent Developments
- 4.15 Ramical
- 4.15.1 Ramical Company Information
- 4.15.2 Ramical Business Overview
- 4.15.3 Ramical Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Ramical Home Pet Deworming Medicine Product Portfolio
- 4.15.5 Ramical Recent Developments
- 4.16 Beaphar
- 4.16.1 Beaphar Company Information
- 4.16.2 Beaphar Business Overview
- 4.16.3 Beaphar Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Beaphar Home Pet Deworming Medicine Product Portfolio
- 4.16.5 Beaphar Recent Developments
- 4.17 Agland
- 4.17.1 Agland Company Information
- 4.17.2 Agland Business Overview
- 4.17.3 Agland Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Agland Home Pet Deworming Medicine Product Portfolio
- 4.17.5 Agland Recent Developments
5 Global Home Pet Deworming Medicine Market Scenario by Region
- 5.1 Global Home Pet Deworming Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Home Pet Deworming Medicine Sales by Region: 2021-2032
- 5.2.1 Global Home Pet Deworming Medicine Sales by Region: 2021-2026
- 5.2.2 Global Home Pet Deworming Medicine Sales by Region: 2027-2032
- 5.3 Global Home Pet Deworming Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Home Pet Deworming Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Home Pet Deworming Medicine Revenue by Region: 2027-2032
- 5.4 North America Home Pet Deworming Medicine Market Facts & Figures by Country
- 5.4.1 North America Home Pet Deworming Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Home Pet Deworming Medicine Sales by Country (2021-2032)
- 5.4.3 North America Home Pet Deworming Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Home Pet Deworming Medicine Market Facts & Figures by Country
- 5.5.1 Europe Home Pet Deworming Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Home Pet Deworming Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Home Pet Deworming Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Home Pet Deworming Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Home Pet Deworming Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Home Pet Deworming Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Home Pet Deworming Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Home Pet Deworming Medicine Market Facts & Figures by Country
- 5.7.1 South America Home Pet Deworming Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Home Pet Deworming Medicine Sales by Country (2021-2032)
- 5.7.3 South America Home Pet Deworming Medicine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Home Pet Deworming Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Home Pet Deworming Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Home Pet Deworming Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Home Pet Deworming Medicine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Home Pet Deworming Medicine Sales by Type (2021-2032)
- 6.1.1 Global Home Pet Deworming Medicine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Home Pet Deworming Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Home Pet Deworming Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Home Pet Deworming Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Home Pet Deworming Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Home Pet Deworming Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Home Pet Deworming Medicine Sales by Application (2021-2032)
- 7.1.1 Global Home Pet Deworming Medicine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Home Pet Deworming Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Home Pet Deworming Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Home Pet Deworming Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Home Pet Deworming Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Home Pet Deworming Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Home Pet Deworming Medicine Value Chain Analysis
- 8.1.1 Home Pet Deworming Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Home Pet Deworming Medicine Production Mode & Process
- 8.2 Home Pet Deworming Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Home Pet Deworming Medicine Distributors
- 8.2.3 Home Pet Deworming Medicine Customers
9 Global Home Pet Deworming Medicine Analyzing Market Dynamics
- 9.1 Home Pet Deworming Medicine Industry Trends
- 9.2 Home Pet Deworming Medicine Industry Drivers
- 9.3 Home Pet Deworming Medicine Industry Opportunities and Challenges
- 9.4 Home Pet Deworming Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst